medigraphic.com

2005, Number 2

Rev Cent Dermatol Pascua 2005; 14 (2)

Onchocerciasis

Castro E, González G

Language: Spanish
References: 14
Page: 75-78
PDF size: 106.43 Kb.


ABSTRACT

Onchocerciasis is an infectious disease common in best and central Africa, Central and South America, and the Arabian Peninsula. Onchocerciasis is the second leading infectious cause of blindness world-wide. Onchocerca volvulus is a filarial nematode, the etiologic agent of onchocerciasis. Clinically, takes two forms: eye disease, and skin disease. Diagnosis is made through slitlamp examination, as well as by demonstration of filarial worms. Patients are treated with oral or intravenous ivermectin at a dose of 150 µg/kg once every 6 months for up to 10 years.


REFERENCES

  1. Burnham B. Onchocerciasis. The Lancet 1998; 351: 1341-46.

  2. Lance C, Peters J. Onchocerciasis (River Blindness). Cutis 2003; 72: 297-302.

  3. Stringl P. Onchocerciasis: clinical presentation and host parasite interactions in patients of Southern Sudan. Inter J Dermatol 1997; 36: 23-28.

  4. Elgart M. Onchocerciasis. Dermatol Clin 1989; 7: 322-328.

  5. Ottesen E. Immune responsiveness and the pathogenesis of human onchocerciasis. J Infect Dis 1995; 171: 659-671.

  6. Gallais V, Chosidow O, Caumes E. Enciclopedia Médico-Quirúrgica. 2002: 98-415-A-10.

  7. Murdoch M. A clinical classification and grading system of the cutaneous changes in onchocerciasis. Br J Dermatol 1993; 129: 260-269.

  8. Vernick W, Turner S. Onchocercosis presenting with lower extremity, hypopigmented macules. Cutis 2000; 65: 293-297.

  9. Abiose A, Jones B. Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis. Lancet 1993; 341: 153-56.

  10. Taylor H, Munoz B, Keyvan E et al. Reliability of detection of microfilariae in skin snips in the diagnosis of onchocerciasis. Am J trop Med 1989; 41: 467-471.

  11. Zimmerman P, Guderian R, Aruajo E et al. Polymerase Chain reaction-based diagnosis of Onchocerca volvulus infection: improved detection of patients with onchocerciasis. J Infect Dis 1994; 169: 686-689.

  12. Laethem Y, López C. Treatment of Onchocerciasis. Drugs 1996; 52: 661-869.

  13. Goa K, Tavish D. Ivermectin: a review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis. Drugs 1991; 42: 640-658.

  14. De Sole G, Remme J. Adverse reactions after mass treatment of onchocerciasis with ivermectin. Trop Med Parasitol 1998; 39: 331-346.




2020     |     www.medigraphic.com